ADA, EASD advice against using Avandia

The American Diabetes Association and the European Association for the Study of Diabetes have released a consensus statement advising against the use of rosiglitazone (Avandia).  In fairness, the consensus statement acknowledges that the recommendation is based on meta-analysis data that is less than conclusive.  Still, this is another major hit against GlaxoSmithKline’s TZD drug.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: